Dalbavancin
CAS: 171500-79-1
Ref. TM-T21358
1mg | 59.00 € | ||
5mg | 125.00 € | ||
10mg | 182.00 € | ||
25mg | 365.00 € | ||
50mg | 551.00 € | ||
100mg | 783.00 € | ||
1ml*10 (DMSO) | 191.00 € |
Product Information
- BI 397, BI-397, VER 001, A-A 1, BI397, VER-001, Dalbavancin HCl
- 5,31-Dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-β-<span class="text-smallcaps">D</smallcap>-glucopyranuronosyl]-38-[[[3-(dimethylamino)propyl]amino]carbonyl]-42-O-α-<smallcap>D</span>-mannopyranosyl-N<sup>15</sup>-methylristomycin A aglycone
- A-A 1
- B 7011
- Bi-397
- Dalbavancin B<sub>0</sub>
- Dalvance
- Mdl 63397
- Ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-β-<span class="text-smallcaps">D</smallcap>-glucopyranuronosyl]-38-[[[3-(dimethylamino)propyl]amino]carbonyl]-42-O-α-<smallcap>D</span>-mannopyranosyl-N<sup>15</sup>-methyl-
- V-Glycopeptide
- See more synonyms
- Ver 001
Dalbavancin (BI-397), a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE),Dalbavancin inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively
Chemical properties
Technical inquiry about: TM-T21358 Dalbavancin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.